A patient diagnosed with hepatitis B begins treatment with Adefovir and ask how long the drug therapy will last. what time frame will the prescriber give the patient?

Questions 263

ATI RN

ATI RN Test Bank

Advanced Pharmacology Across the Lifespan Questions

Question 1 of 5

A patient diagnosed with hepatitis B begins treatment with Adefovir and ask how long the drug therapy will last. what time frame will the prescriber give the patient?

Correct Answer: D

Rationale: The correct answer is D: An indefinite, prolonged period of time. Adefovir is typically used as a long-term treatment for chronic hepatitis B to suppress the virus and prevent liver damage. Treatment duration is often indefinite as stopping the medication can lead to viral reactivation. Choice A is incorrect as waiting for nephrotoxicity to occur before stopping treatment is not a safe practice. Choice B is incorrect as lifetime treatment is not always necessary. Choice C is incorrect as 48 weeks is not sufficient for chronic hepatitis B treatment.

Question 2 of 5

Which of the following diseases or disorders are most likely treated with ACE inhibitors?

Correct Answer: E

Rationale: I apologize for the error in the question. However, if we assume the correct answer is meant to be "D: Angina," the rationale is as follows: ACE inhibitors are commonly used to treat angina by dilating blood vessels, reducing blood pressure, and improving blood flow to the heart. Other choices are incorrect because ACE inhibitors are not typically used to treat hyperthyroidism, pulmonary hypertension, or Cushing's syndrome.

Question 3 of 5

Which term refers to the ratio between the drugs therapeutic effects and its toxic effects?

Correct Answer: B

Rationale: The correct answer is B: Therapeutic index. The therapeutic index is the ratio between the drug's desired therapeutic effects and its toxic effects. It indicates the margin of safety of a drug. A: Cumulative effect refers to the increased potency or adverse effects of a drug when taken repeatedly. C: Tolerance is the decreasing response to a drug over time, requiring higher doses for the same effect. D: Affinity is the strength of binding between a drug and its target receptor, not directly related to the drug's therapeutic and toxic effects. Therefore, the correct choice is B as it specifically addresses the ratio between therapeutic and toxic effects.

Question 4 of 5

A patient has a blood pressure of 150/95 mm HG and 148/90 mm Hg on two separate office visits. This is consistent with a blood pressure of 145/92 mm Hg taken in an ambulatory setting. The patient's diagnostic tests are all normal. What will the patient's provider order to best manage the patient's hypertension?

Correct Answer: A

Rationale: The correct answer is A: A thiazide diuretic. Thiazide diuretics are recommended as the initial medication for managing hypertension in patients without compelling indications. They are effective in lowering blood pressure by reducing the volume of circulating blood. In this case, the patient's blood pressure readings are consistently elevated, indicating the need for pharmacological management. Thiazide diuretics have been shown to reduce cardiovascular events and mortality in hypertensive patients. Loop diuretics and Spironolactone (Choice B) are not first-line treatments for hypertension and are typically used in specific cases like heart failure. Beta blockers (Choice C) are not the preferred initial treatment for hypertension in the absence of other compelling indications. Thus, the most appropriate choice for managing this patient's hypertension would be a thiazide diuretic.

Question 5 of 5

Which of the following groups of antibiotics finds to the 50S subunit of the bacterial ribosome and includes drugs such as Erythromycin and azithromycin?

Correct Answer: B

Rationale: The correct answer is B: Macrolides. Macrolides bind to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis. Erythromycin and azithromycin are examples of macrolide antibiotics. The other choices are incorrect because: A: Fluoroquinolones inhibit bacterial DNA gyrase and topoisomerase IV. C: Aminoglycosides bind to the 30S subunit of the bacterial ribosome. D: Tetracyclines inhibit protein synthesis by binding to the 30S subunit of the bacterial ribosome.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions